Cited by 10Gestational Diabetes Research and ManagementThyroid Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Can Thyroid Screening in the First Trimester Improve the Prediction of Gestational Diabetes Mellitus?

Open access
Milovanović, Zagorka, Filimonović, Dejan, Soldatović, Ivan, Karadžov Orlić, Nataša·2022·Journal of Clinical Medicine

Abstract

This study aimed to evaluate the clinical utility of the subclinical hypothyroidism (SCH) marker, elevated thyroid-stimulating hormone (TSH) and thyroid antibodies in their ability to predict subsequent gestational diabetes mellitus (GDM). In a prospective clinical trial, 230 pregnant women were screened for thyroid function during the first trimester of pregnancy. Increased TSH levels with normal free thyroxine (fT4) were considered SCH. The titers of thyroid peroxidase antibody (anti TPO Ab) at >35 IU/mL and thyroglobulin antibody (anti Tg Ab) at >115 IU/mL were considered as antibodies present. According to the OGTT results, the number of pregnant women with GDM showed the expected growth trend, which was 19%. Two groups of pregnant women were compared, one with GDM and the other without. Increased TSH levels and the presence of thyroid antibodies showed a positive correlation with the risk of GDM. TSH levels were significantly higher in pregnant women with GDM, p = 0.027. In this study, 25.6% of pregnant women met the diagnostic criteria for autoimmune thyroiditis. Hashimoto’s thyroiditis was significantly more common in GDM patients, p < 0.001. Through multivariate logistic regression, it was demonstrated that patient age, TSH 4 IU/mL, and anti TPO Ab > 35 IU/mL are significant predictors of gestational diabetes mellitus that may improve first-trimester pregnancy screening performance, AUC: 0.711; 95% CI: 0.629–0.793.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm11133916

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Serbia, ADA or IADPSG criteria for GDM diagnosis are used; earlier, 100 g OGTT was used in high-risk patients.

    “In Serbia the ADA or IADPSG criteria for GDM diagnosis are used [189,190,191]. Earlier, the 100 g OGTT was used in high-risk patients [189].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [191]

    Materials and Methods §2.2 (page unavailable) says this Serbian study diagnosed GDM using IADPSG/WHO criteria with a 75 g OGTT. It does not establish that ADA criteria are used in Serbia or say that high-risk patients previously received a 100 g OGTT. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In Serbia, Milovanovic et al. presented a lower GDM incidence of 19.5%.

    “A lower GDM incidence (19.5%) was presented by Milovanovic et al. in their study assessing usefulness of thyroid screening in GDM prediction [191].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. Bouariu, A., Panaitescu, A.M., and Nicolaides, K.H. (2022). First Trimester Prediction of Adverse Pregnancy Outcomes-Identifying Pregnancies at Risk from as Early as 11–13 Weeks. Medicina, 58. · DOI
  2. Hage, 2011, Thyroid Disorders and Diabetes Mellitus, J. Thyroid. Res., 2011, 1, 10.4061/2011/439463 · DOI
  3. Giannakou, K., Evangelou, E., Yiallouros, P., Christophi, C.A., Middleton, N., Papatheodorou, E., and Papatheodorou, S.I. (2019). Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies. PLoS ONE, 14. · DOI
  4. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger, B.E., Gabbe, S.G., Persson, B., Buchanan, T.A., Catalano, P.A., Damm, P., Dyer, A.R., de Leiva, A., and Hod, M. (2010). International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care, 33, 676–682. · DOI · Paper page
  5. Lende, M., and Rijhsinghani, A. (2020). Gestational Diabetes: Overview with Emphasis on Medical Management. Int. J. Environ. Res. Public Health, 17. · DOI · Paper page
  6. Carreiro, M.P., Nogueira, A.I., and Ribeiro-Oliveira, A. (2018). Controversies and Advances in Gestational Diabetes-An Update in the Era of Continuous Glucose Monitoring. J. Clin. Med., 7. · DOI
  7. Abalovich, 2011, Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum, Thyroid., 21, 1081, 10.1089/thy.2011.0087 · DOI · Paper page
  8. Allan, 2000, Maternal Thyroid Deficiency and Pregnancy Complications: Implications for Population Screening, J Med. Screen, 7, 127, 10.1136/jms.7.3.127 · DOI
  9. Casey, 2007, Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy, Obstet. Gynecol., 109, 1129, 10.1097/01.AOG.0000262054.03531.24 · DOI
  10. Potlukova, 2012, Is Age a Risk Factor for Hypothyroidism in Pregnancy? An Analysis of 5223 Pregnant Women, J. Clin. Endocrinol. Metab., 97, 1945, 10.1210/jc.2011-3275 · DOI
  11. Lazarus, 2014, 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children, Eur. Thyroid. J., 3, 76, 10.1159/000362597 · DOI · Paper page
  12. Alexander, 2017, 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum, Thyroid, 27, 315, 10.1089/thy.2016.0457 · DOI · Paper page
  13. Lazarus, 2011, Screening for Thyroid Dysfunction in Pregnancy: Is It Worthwhile?, J. Thyroid. Res., 2011, 1, 10.4061/2011/397012 · DOI
  14. Azizi, 2014, Thyroid Derangements in Pregnancy, Iran. J. Endocrinol. Metab., 15, 491
  15. Leo, 2018, Autoimmune Thyroid Disease during Pregnancy, Lancet Diabetes Endocrinol., 6, 575, 10.1016/S2213-8587(17)30402-3 · DOI
  16. Gheorghiu, M.L., Bors, R.G., Gheorghisan-Galateanu, A.A., Pop, A.L., Cretoiu, D., and Varlas, V.N. (2021). Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug. J. Clin. Med., 10. · DOI
  17. Harn-A-Morn, P., Dejkhamron, P., Tongsong, T., and Luewan, S. (2021). Pregnancy Outcomes among Women with Graves’ Hyperthyroidism: A Retrospective Cohort Study. J. Clin. Med., 10. · DOI
  18. Abalovich, 2002, Overt and Subclinical Hypothyroidism Complicating Pregnancy, Thyroid, 12, 63, 10.1089/105072502753451986 · DOI · Paper page
  19. Ashoor, 2010, Maternal Thyroid Function at 11 to 13 Weeks of Gestation and Subsequent Fetal Death, Thyroid, 20, 989, 10.1089/thy.2010.0058 · DOI
  20. Davis, 1988, Hypothyroidism Complicating Pregnancy, Obstet. Gynecol., 72, 108
  21. Tudela, 2012, Relationship of Subclinical Thyroid Disease to the Incidence of Gestational Diabetes, Obstet. Gynecol., 119, 983, 10.1097/AOG.0b013e318250aeeb · DOI
  22. Biondi, 2019, Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders, Endocr. Rev., 40, 789, 10.1210/er.2018-00163 · DOI · Paper page
  23. Kahaly, 2017, Polyglandular Autoimmune Syndromes, J Endocrinol. Investig., 41, 91, 10.1007/s40618-017-0740-9 · DOI
  24. Olivieri, 2000, High Frequency of Antithyroid Autoantibodies in Pregnant Women at Increased Risk of Gestational Diabetes Mellitus, Eur. J. Endocrinol., 143, 741, 10.1530/eje.0.1430741 · DOI
  25. Agarwal, 2006, Thyroid Function Abnormalities and Antithyroid Antibody Prevalence in Pregnant Women at High Risk for Gestational Diabetes Mellitus, Gynecol. Endocrinol., 22, 261, 10.1080/09513590600630470 · DOI
  26. Malone, 2008, Maternal Thyroid Hypofunction and Pregnancy Outcome, Obstet. Gynecol., 112, 85, 10.1097/AOG.0b013e3181788dd7 · DOI
  27. Yanachkova, 2021, The Relationship between Thyroid Dysfunction during Pregnancy and Gestational Diabetes Mellitus, Endokrynol. Pol., 72, 226, 10.5603/EP.a2021.0016 · DOI · Paper page
  28. Corrales, 2014, ¿Existe mayor riesgo de diabetes gestacional en pacientes con disfunción tiroidea autoinmune?, Endocrinol Nutr., 61, 377, 10.1016/j.endonu.2014.01.009 · DOI
  29. Karakosta, 2012, Thyroid Dysfunction and Autoantibodies in Early Pregnancy Are Associated with Increased Risk of Gestational Diabetes and Adverse Birth Outcomes, J. Clin. Endocrinol. Metab., 97, 4464, 10.1210/jc.2012-2540 · DOI
  30. Huang, 2019, Isolated Effect of Maternal Thyroid-Stimulating Hormone, Free Thyroxine and Antithyroid Peroxidase Antibodies in Early Pregnancy on Gestational Diabetes Mellitus: A Birth Cohort Study in China, Endocr. J., 66, 223, 10.1507/endocrj.EJ18-0340 · DOI
  31. Korevaar, 2018, The Upper Limit for TSH during Pregnancy: Why We Should Stop Using Fixed Limits of 2.5 or 3.0 MU/l, Thyroid. Res., 11, 5, 10.1186/s13044-018-0048-7 · DOI
  32. Pagana, K.D., Pagana, T.J., and Pagana, T.N. (2019). Mosby’s Diagnostic and Laboratory Test Reference, Elsevier Science. [14th ed.].
  33. He, 2014, Comparison of the effect of different diagnostic criteria of subclinical hypothyroidism and positive TPO-Ab on pregnancy outcomes, Zhonghua Fu Chan Ke Za Zhi, 49, 824
  34. Negro, 2010, Increased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy, J. Clin. Endocrinol. Metab., 95, E44, 10.1210/jc.2010-0340 · DOI
  35. Toulis, 2014, Maternal Subclinical Hypothyroidsm and Gestational Diabetes Mellitus: A Meta-Analysis, Endocr. Pract., 20, 703, 10.4158/EP13440.RA · DOI
  36. Jia, 2018, Meta-Analysis of the Association between Maternal Subclinical Hypothyroidism and Gestational Diabetes Mellitus, Int. J. Gynecol. Obstet., 144, 239, 10.1002/ijgo.12751 · DOI
  37. Stohl, 2013, Thyroid Disease and Gestational Diabetes Mellitus (GDM): Is There a Connection?, J. Matern.-Fetal Neonatal Med., 26, 1139, 10.3109/14767058.2013.773309 · DOI
  38. Ying, 2016, Maternal TSH Level and TPOAb Status in Early Pregnancy and Their Relationship to the Risk of Gestational Diabetes Mellitus, Endocrine, 54, 742, 10.1007/s12020-016-1022-6 · DOI
  39. Cai, 2021, Autoimmune Thyroid Disease Correlates to Islet Autoimmunity on Zinc Transporter 8 Autoantibody, Endocr. Connect., 10, 534, 10.1530/EC-20-0650 · DOI
  40. Drugarin, 2000, The Pattern of a TH1 Cytokine in Autoimmune Thyroiditis, Immunol. Lett., 71, 73, 10.1016/S0165-2478(99)00156-X · DOI
  41. Al-ofi, E.A. (2019). Implications of Inflammation and Insulin Resistance in Obese Pregnant Women with Gestational Diabetes: A Case Study. SAGE Open Med. Case Rep., 7. · DOI
  42. Blaslov, 2020, The Association of Subclinical Insulin Resistance with Thyroid Autoimmunity in Euthyroid Individuals, Acta Clin. Croat, 59., 696
  43. Huhn, 2018, Controversies in Screening and Diagnostic Criteria for Gestational Diabetes in Early and Late Pregnancy, Front. Endocrinol., 9, 696, 10.3389/fendo.2018.00696 · DOI

Cited by

Sorted by citations

Metadata

Authors
Milovanović, Z., Filimonović, D., Soldatović, I., & Karadžov Orlić, N.
Affiliations
  • University of Belgrade (RS)
  • Clinic for Gynaecology and Obstetrics Narodni Front, Kraljice Natalije 62, 11000 Belgrade, Serbia
Corresponding author
Milovanović, Zagorka
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2022-07-05
Volume
11
Issue
13
Pages
3916
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4284708683
Cited by
10
References
3
Citations by year
2026: 1 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 1
FWCI
2.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
gestational diabetes mellitus, subclinical hypothyroidism, thyroid screening, first trimester, thyroid-stimulating hormone, thyroid peroxidase antibodies, thyroglobulin antibodies, Hashimoto's thyroiditis, autoimmune thyroiditis, risk prediction, pregnancy screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review